Common use of Outline of Study Clause in Contracts

Outline of Study. This will be a prospective, randomized, crossover, double-masked study comparing 2 contact lenses. The expected duration of subject participation in the study is approximately 20 days, with 3 scheduled visits. The study is expected to be completed in approximately 5 weeks.

Outline of Study. This will be a multi-site, prospective, randomized, parallel crossover, double-masked study comparing 2 4 contact lenses. The expected duration of subject participation in the study is approximately 20 days, with 3 scheduled visits. The study is expected to be completed in approximately 5 7 weeks.

Outline of Study. This will be a multi-site, prospective, randomizedsingle arm, crossover, doubleopen-masked label study comparing 2 examining 1 type of contact lenseslens. The expected duration of subject participation in the study is approximately 20 days2 weeks, with up to 3 scheduled visits. The study is expected to be completed in approximately 5 weeks. All subjects will be receive the test lens to wear bilaterally throughout the study duration. 4.1 Identity of Study Treatments

Outline of Study. This will be a multi-site, prospective, randomizedsingle arm, crossover, doubleopen-masked label study comparing 2 examining 1 type of contact lenseslens. The expected duration of subject participation in the study is approximately 20 7 days, with up to 3 scheduled visits. The study is expected to be completed in approximately 5 6 weeks. All subjects will receive the test lens to wear bilaterally throughout the study duration. 4.1 Identity of Study Treatments Test Lens LID Number LID021201 .

Outline of Study. This will be a multi-site, prospective, randomized, crossover, doublesubject-masked study comparing 2 contact lenses. The expected duration of subject participation in the study is approximately 20 up to 64 days, with 3 5 scheduled visits. The study is expected to be completed in approximately 5 weeks3 months. Subjects will be randomized in a 1:1 manner to receive treatment in crossover sequence: Test product then Control product or Control product then Test product, respectively. 4.1 Identity of Study Treatments

Outline of Study. This will be a prospective, multi-site, randomized, crossoverparallel-group, doubleopen-masked label study comparing 2 daily disposable contact lenses. The expected duration of subject participation in the study is approximately 20 days4 weeks, with 3 scheduled visits. The study is expected to be completed in approximately 5 8 weeks. Subjects will be randomized in a 1:1 manner to receive treatment with DAILIES TOTAL1 or Acuvue Oasys 1-Day. 4.1 Identity of Study Treatments